Friday, November 28, 2014 Last update: 11:03 AM - Covering Large & Obscure Tech Companies Since 1996

Dynavax to Present at the 34th Annual Cowen & Company Health Care Conference

Companies mentioned in this article: Dynavax Technologies

BERKELEY, CA -- (Marketwired) -- 02/28/14 -- Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it will present at the 34th Annual Cowen & Company Health Care Conference in Boston on Tuesday, March 4, 2014 at 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time).

Eddie Gray, Chief Executive Officer of Dynavax, will provide a company overview. To access the slide presentation, live webcast, and subsequent archived recording, please visit Dynavax's website at

About Dynavax
Dynavax, a clinical-stage biopharmaceutical company, discovers and develops novel vaccines and therapeutics in the areas of infectious and inflammatory diseases and oncology. Dynavax's lead product candidate is HEPLISAV-B, a Phase 3 investigational adult hepatitis B vaccine. For more information visit


Michael Ostrach
Vice President and Chief Business Officer
Email Contact